The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

PEBI PORT ERIN BIOPHARMA INVESTMENTS LIMITED ORD 0.0001P




We are now using data from FTSE Russell Data Solutions. FTSE Russell is a leading global provider of benchmarks, analytics and data solutions with multi-asset capabilities. Global Company Fundamentals provides profiles on global active and inactive companies from over 100 countries including over 25 years of as-reported financials and standardised financials based on globally accepted XBRL taxonomies for active companies. As a result of this change in data provider, you may see some differences to the data. For further information please contact lse-website@lseg.com
Income Statement 30-Jun-13
( £ m )
30-Jun-14
( £ m )
30-Jun-15
( £ m )
30-Jun-16
( £ m )
30-Jun-17
( £ m )
Continuing Operations
Revenue  0.59 2.10 -0.19 -0.32 0.18
Operating Profit/(Loss)  0.41 1.38 -0.60 -0.53 -0.05
Net Interest  0.01 n/a n/a n/a n/a
Profit Before Tax  0.42 1.38 -0.60 -0.53 -0.04
Profit After Tax  n/a n/a n/a n/a n/a
Discontinued Operations
Profit After Tax  n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD  0.42 1.38 -0.60 -0.53 -0.04
Attributable to:
Minority Interests  n/a n/a n/a n/a n/a
Equity Holders of Parent Company  0.42 1.38 -0.60 -0.53 -0.04
 
Continuing EPS
Earnings per Share - Basic  1.25p 4.08p -2.03p -2.30p -0.16p
Earnings per Share - Diluted  1.25p 4.08p -2.03p -2.30p -0.16p
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
Continuing and Discontinued EPS
Earnings per Share - Basic  1.25p 4.08p -2.03p -2.30p -0.16p
Earnings per Share - Diluted  1.25p 4.08p -2.03p -2.30p -0.16p
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
 
Dividend per Share  n/a n/a n/a n/a n/a

Balance Sheet 30-Jun-13
( £ m )
30-Jun-14
( £ m )
30-Jun-15
( £ m )
30-Jun-16
( £ m )
30-Jun-17
( £ m )
Assets
Non-Current Assets
Property, Plant & Equipment  n/a n/a n/a n/a n/a
Intangible Assets  n/a n/a n/a n/a n/a
Investment Properties  n/a n/a n/a n/a n/a
Investments  n/a n/a n/a n/a n/a
Other Financial Assets  n/a n/a n/a n/a n/a
Other Non-Current Assets  n/a n/a n/a n/a n/a
  n/a n/a n/a n/a n/a
Current Assets
Inventories  n/a n/a n/a n/a n/a
Trade & Other Receivables  0.01 0.02 0.01 0.01 0.22
Cash at Bank & in Hand  0.71 0.53 0.26 0.01 0.88
Current Asset Investments  2.92 4.83 2.45 2.19 1.05
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  3.63 5.38 2.72 2.21 2.15
 
Total Assets  3.63 5.38 2.72 2.21 2.15
 
Liabilities
Current Liabilities
Borrowings  n/a n/a n/a n/a n/a
Other Current Liabilities  0.01 0.02 0.02 0.03 0.03
  0.03 0.40 0.03 0.05 0.03
 
Net Current Assets  3.60 4.98 2.69 2.15 2.12
 
Non-Current Liabilities
Borrowings  0.00 0.00 0.00 0.00 0.00
Provisions  n/a n/a n/a n/a n/a
Other Non-Current Liabilities  n/a n/a n/a n/a n/a
  n/a n/a n/a n/a n/a
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  0.03 0.40 0.03 0.05 0.03
 
Net Assets  3.60 4.98 2.69 2.15 2.12
 
Capital & Reserves
Share Capital  n/a n/a n/a n/a n/a
Share Premium Account  2.76 2.76 1.89 1.89 1.89
Other Reserves  n/a n/a n/a n/a n/a
Retained Earnings  0.84 2.22 0.80 0.26 0.23
Shareholders Funds  3.60 4.98 2.69 2.15 2.12
 
Minority Interests/Other Equity  n/a n/a n/a n/a n/a
Total Equity *   3.60 4.98 2.69 2.15 2.12

Ratios - based on IFRS 30-Jun-13 30-Jun-14 30-Jun-15 30-Jun-16 30-Jun-17
Continuing Operations
PE Ratio *   5.80 2.94 n/a n/a n/a
PEG *   -0.19 0.01 n/a n/a n/a
Earnings per Share Growth  -30.94% 226.40% n/a n/a n/a
Dividend Cover *   n/a n/a n/a n/a n/a
Revenue Per Share  1.77p 6.20p -0.64p -1.37p 0.78p
Pre-Tax Profit per Share  1.25p 4.08p -2.03p -2.30p -0.16p
Operating Margin  69.01% 65.82% n/a n/a -25.92%
Return on Capital Employed  12.09% 32.20% -15.70% -22.03% -2.20%
 
Continuing & Discontinued Operations
Dividend Yield *   n/a n/a n/a n/a n/a
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  10.63p 14.71p 11.58p 9.28p 9.12p
Net Gearing *   n/a n/a n/a n/a n/a

Data provided by FTSE Russell



Market

Company Information
Company website http://www.porterinbiop...
Company address 18 Athol Street, Douglas, IM1 1JA, United Kingdom
FTSE ICB sector Pharmaceuticals & Biotechnology
FTSE ICB subsector Biotechnology
Company market cap, £m* 1.04
Admission date 15 Sep 2011
*The market capitalisation of companies reflects the London listed element only and are approximate. Data provided by FTSE Russell.

Security Information
25-Jun-18
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
Market AIM
Market identifier code (MIC) AIMX
Trading service SETSqx
Trading segment ASQ1
Listing category -
Country of share register IM
ISIN IM00B6QH1J21
SEDOL B6QH1J2
Exchange market size 7,500
Security market cap, £m 1.04



PORT ERIN share fundamentals (PEBI)